After a study showed that the supplement affected the hormone that’s related to male pattern baldness, guys freaked out. We ...

THOUSANDS of adults and teenagers with severe hair loss could benefit from a drug already prescribed on the NHS. Upadacitinib, sold under the brand name Rinvoq, is currently offered by the health ...

Two major trials show a JAK inhibitor drug helped over half of severe alopecia patients regrow most of their hair.

Researchers have found in a new study that topical finasteride 0.25% monotherapy was well tolerated and significantly improved hair density, hair thickness, and the terminal-to-vellus hair ...

Low-dose oral minoxidil ranks high as a first-line alopecia treatment option for transmasculine individuals and, especially ...

A recent study discovered that a commonly-prescribed arthritis drug showed promise in strong hair regrowth in patients ...

The BMJ study examined over 50,000 people with Type 2 diabetes taking GLP-1 receptor stimulants, comparing them with patients ...

Research shows GLP-1 receptor agonists like semaglutide and tirzepatide may increase the risk of alopecia, highlighting the ...

A common arthritis drug has been found to boost hair growth in clinical trials, with over half of alopecia patients achieving ...

Upadacitinib, an oral selective JAK inhibitor, significantly improved scalp hair regrowth and quality of life vs placebo in adults and adolescents with severe alopecia areata (AA) in two phase 3 ...

HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune ...